Morgan Stanley analyst Tejas Savant maintains $Thermo Fisher Scientific (TMO.US)$ with a buy rating, and adjusts the target price from $680 to $670.
According to TipRanks data, the analyst has a success rate of 38.0% and a total average return of -6.5% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Thermo Fisher Scientific (TMO.US)$'s main analysts recently are as follows:
The company delivered financial results that met expectations in a period where anticipation was high. It is recognized for maintaining strong performance amidst a challenging demand landscape for tools, with limited insight into when demand might rebound.
While the company's Q3 earnings call presented a more upbeat outlook than the actual results, there remains a positive sentiment towards the stock. Momentum in the Life Sciences Solutions segment is noted, particularly in bioproduction, and the Laboratory Products and Biopharma Services segment appears to be insulated from the biotech slowdown.
The firm notes that Thermo Fisher's core growth is showing a consistent improvement quarter-over-quarter, with guidance suggesting a slight increase to around +2.5% in the fourth quarter. The expectations of a 5% core growth by 2025 also appear to be reasonable and justifiable. The firm appreciates Thermo Fisher's resilient profile and the flexibility provided by its balance sheet.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
